name | wmh |
sex | male
|
age | 43 岁 |
hospital number | 17032025 |
height | 162 cm |
weight | 57 kg |
BSA | 1.621 m2 |
APACHEⅡ | 18 分 |
Infection source | urinary
|
date | 2017/9/16 年/月/日 |
Sequential Organ Failure Assessment | 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
|
age>=60 | no
|
septic shock | yes
|
mechanical ventilation | |
Early fluid resuscitation | yes
|
age<60 | yes
|
Pregnant woman | no
|
advanced malignant tumor | |
Pulmonary interstitial fibrosis | |
Serious arrhythmia | |
Small Tidal Volume Ventilation | |
Liver failure | |
Refuse to participate |
Heart disease | no
|
yes
|
|
no
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
亚胺培南西司他丁钠 |
|
vasoactive agent | no
|
15 min |
|
30 min |
|
15 min |
Temperature | 37.2 ℃ |
Heart Rate | 101 次/分 |
Breath | 15 次/分 |
Systolic pressure (SP) | 89 mmHg |
Diastolic pressure | 59 mmHg |
mean arterial pressure | 72 mmHg |
Pcv-aCO2 | 4 mmHg |
DO2 | 601.63 |
VO2 | 134.36 |
Ca-vO2 | 25.73 |
pH value | 7.37 |
PaO2 | 171 mmHg |
PaCO2 | 30 mmHg |
BE | -7.3 mmol/L(±2.3mmol/L) |
SaO2 | 99.4 % |
Blood lactic acid concentration, LAC | 2.5 mmol/L |
Oxygenation index (PaO2/FiO2) | 518.18 mmHg |
pH value | 7.3 |
PcvO2 | 61 mmHg |
PcvCO2 | 34 mmHg |
BE | -8.5 mmol/L |
ScvO2 | 77.1 % |
Volume of input | ml |
Volume of output | 210 ml |
Volume of urine | 210 ml |
ultrafiltration volume | 0 ml |
norepinephrine | no
|
Norepinephrine Dosage | μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 7 mmHg |
cardiac output | 5.29 L/min |
cardiac index | 3.52 L/min/m2 |
stroke volume | 51 ml |
Stroke Index | 36 ml/m2 |
ITBVI | 818 ml/m2 |
GEDVI | 654 ml/m2 |
EVLWI | 6 ml/kg |
PVPI | 1.2 |
SVRI | 1759 DSm2/cm5 |
CFI | 5.6 |
GEF | 22 % |
SVV | 10 % |
PPV | 6 % |
dPmax | 1249 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 条 |
LUS | 00 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18.1 mm |
IVC(expiratory phase) | 16.4 mm |
respiratory variations of inferior vena cavae diameter | 9.86 % |
mm |
|
mm |
|
mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 18.1 mm |
IVC(expiratory phase) | 16.4 mm |
Respiratory variations of inferior vena cavae diameter | 9.86 % |
mm |
|
mm |
|
mm |
|
mm |
Temperature | 36.5 ℃ |
Heart Rate | 108 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 106 mmHg |
Diastolic Pressure | 62 mmHg |
Mean Arterial Pressure | 76 mmHg |
Pcv-aCO2 | 6.0 mmHg |
DO2 | 619.68 |
VO2 | 130.01 |
Ca-vO2 | 22.98 |
PH value | 7.34 |
PaO2 | 95.2 mmHg |
PaCO2 | 26 mmHg |
BE | -10.9 mmol/L |
SaO2 | 96.50 % |
Blood Lactic Acid Concentration | 1.9 mmol/L |
Oxygenation index (PaO2/FiO2) | 288.48 mmHg |
PH value | 7.31 |
PcvO2 | 51.3 mmHg |
PcvCO2 | 32 mmHg |
BE | -10.1 mmol/L |
ScvO2 | 76.20 % |
Volume of input | ml |
Volume of output | 880 ml |
Volume of urine | 650 ml |
Ultrafiltration Volume | 150 ml |
Norepinephrine Dosage | mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 9 mmHg |
cardiac output | 5.69 L/min |
cardiac index | 3.55 L/min/m2 |
stroke volume | 55 ml |
Stroke Index | 37 ml/m2 |
ITBVI | 851 ml/m2 |
GEDVI | 720 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.3 |
SVRI | 1920 DSm2/cm5 |
CFI | 5.5 |
GEF | 24.0 % |
SVV | 11.0 % |
PPV | 6 % |
dPmax | 1360 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 0 分 |
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.8 ℃ |
Heart Rate | 133 次/分 |
Breath | 15 次/分 |
Systolic Pressure | 86 mmHg |
Diastolic Pressure | 61 mmHg |
Mean Arterial Pressure | 71 mmHg |
Pcv-aCO2 | 4.0 mmHg |
DO2 | 759.39 |
VO2 | 145.97 |
Ca-vO2 | 21.34 |
PH value | 7.29 |
PaO2 | 101 mmHg |
PaCO2 | 26 mmHg |
BE | -13.1 mmol/L |
SaO2 | 96.5 % |
Blood Lactic Acid Concentration | 2 mmol/L |
Oxygenation index (PaO2/FiO2) | 306.06 mmHg |
PH value | 7.27 |
PcvO2 | 50 mmHg |
PcvCO2 | 30 mmHg |
BE | -12.1 mmol/L |
ScvO2 | 77.90 % |
Volume of input | ml |
Volume of output | 1780 ml |
Volume of urine | 1400 ml |
Ultrafiltration Volume | 300 ml |
Norepinephrine Dosage | mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 6 mmHg |
cardiac output | 6.89 L/min |
cardiac index | 3.6 L/min/m2 |
stroke volume | 52 ml |
Stroke Index | 25 ml/m2 |
ITBVI | 888 ml/m2 |
GEDVI | 711 ml/m2 |
EVLWI | 13 ml/kg |
PVPI | 2.7 |
SVRI | 1360 DSm2/cm5 |
CFI | 5.5 |
GEF | 16.0 % |
SVV | 11.0 % |
PPV | 23 % |
dPmax | 1900 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 0 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 20.3 mm |
IVC(expiratory phase) | 18.6 mm |
Respiratory variations of inferior vena cavae diameter | 8.74 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.6 ℃ |
Heart Rate | 70 次/分 |
Breath | 14 次/分 |
Systolic Pressure | 135 mmHg |
Diastolic Pressure | 80 mmHg |
Mean Arterial Pressure | 101 mmHg |
Pcv-aCO2 | 4.5 mmHg |
DO2 | 450.99 |
VO2 | 89.28 |
Ca-vO2 | 20.19 |
PH value | 7.37 |
PaO2 | 104 mmHg |
PaCO2 | 33.5 mmHg |
BE | -5.6 mmol/L |
SaO2 | 97.70 % |
Blood Lactic Acid Concentration | 2.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 315.15 mmHg |
PH value | 7.34 |
PcvO2 | 46 mmHg |
PcvCO2 | 38 mmHg |
BE | -4.9 mmol/L |
ScvO2 | 78.3 % |
Volume of input | ml |
Volume of output | ml |
Volume of urine | 2700 ml |
Ultrafiltration Volume | 316 ml |
Norepinephrine Dosage | mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 17 mmHg |
cardiac output | 4.46 L/min |
cardiac index | 2.96 L/min/m2 |
stroke volume | 65 ml |
Stroke Index | 44 ml/m2 |
ITBVI | 951 ml/m2 |
GEDVI | 761 ml/m2 |
EVLWI | 7 ml/kg |
PVPI | 1.1 |
SVRI | 2992 DSm2/cm5 |
CFI | 4 |
GEF | 22.0 % |
SVV | 5.0 % |
PPV | 6 % |
dPmax | 1352 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 21.5 mm |
IVC(expiratory phase) | 19.1 mm |
Respiratory variations of inferior vena cavae diameter | 11.82 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | ℃ |
Heart Rate | 次/分 |
Breath | 次/分 |
Systolic Pressure | mmHg |
Diastolic Pressure | mmHg |
Mean Arterial Pressure | mmHg |
Pcv-aCO2 | 5.6 mmHg |
DO2 | 0 |
VO2 | 0 |
Ca-vO2 | 17.81 |
PH value | 7.45 |
PaO2 | 101 mmHg |
PaCO2 | 31.8 mmHg |
BE | -2 mmol/L |
SaO2 | 98.10 % |
Blood Lactic Acid Concentration | 1.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 306.06 mmHg |
PH value | 7.41 |
PcvO2 | 42 mmHg |
PcvCO2 | 37.4 mmHg |
BE | -0.8 mmol/L |
ScvO2 | 79.30 % |
Volume of input | ml |
Volume of output | ml |
Volume of urine | ml |
Ultrafiltration Volume | ml |
Norepinephrine Dosage | mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | mmHg |
cardiac output | L/min |
cardiac index | L/min/m2 |
stroke volume | ml |
Stroke Index | ml/m2 |
ITBVI | ml/m2 |
GEDVI | ml/m2 |
EVLWI | ml/kg |
PVPI |
|
SVRI | DSm2/cm5 |
CFI |
|
GEF | % |
SVV | % |
PPV | % |
dPmax |
|
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | mm |
IVC(expiratory phase) | mm |
Respiratory variations of inferior vena cavae diameter | % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | ℃ |
Heart Rate | 次/分 |
Breath | 次/分 |
Systolic Pressure | mmHg |
Diastolic Pressure | mmHg |
Mean Arterial Pressure | mmHg |
Pcv-aCO2 | 6.0 mmHg |
DO2 | 0 |
VO2 | 0 |
Ca-vO2 | 21.19 |
PH value | 7.45 |
PaO2 | 94 mmHg |
PaCO2 | 32.5 mmHg |
BE | -1.3 mmol/L |
SaO2 | 97.70 % |
Blood Lactic Acid Concentration | 1.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 284.85 mmHg |
PH value | 7.4 |
PcvO2 | 40 mmHg |
PcvCO2 | 38.5 mmHg |
BE | -0.9 mmol/L |
ScvO2 | 76.20 % |
Volume of input | ml |
Volume of output | ml |
Volume of urine | ml |
Ultrafiltration Volume | ml |
Norepinephrine Dosage | mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | mmHg |
cardiac output | L/min |
cardiac index | L/min/m2 |
stroke volume | ml |
Stroke Index | ml/m2 |
ITBVI | ml/m2 |
GEDVI | ml/m2 |
EVLWI | ml/kg |
PVPI |
|
SVRI | DSm2/cm5 |
CFI |
|
GEF | % |
SVV | % |
PPV | % |
dPmax |
|
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(expiratory phase) | mm |
Respiratory variations of inferior vena cavae diameter | % |
IVC(inspiratory phase) | mm |
mm |
|
mm |
|
mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1330 pg/ml |
cTNI | 3.62 ng/ml |
Creatine kinase isoenzyme, CKMB | 103 U/L |
Creatinine | 175 umol/L |
Urea nitrogen | 12.55 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 7 X10*9/L |
neutrophilic granulocyte percentage | 97.4 % |
Hb | g/L |
CRP | 123 mg/L |
Procalcitonin, PCT | >100 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1170 pg/ml |
cTNI | 2115 ng/ml |
Creatine kinase isoenzyme, CKMB | 88 U/L |
Creatinine | 109 umol/L |
Urea nitrogen | 6.52 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 32.2 X10*9/L |
neutrophilic granulocyte percentage | 96.1 % |
Hb | g/L |
CRP | 221 mg/L |
Procalcitonin, PCT | 43.7 ng/ml |
Sequential Organ Failure Assessment | 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1330 pg/ml |
cTNI | 1.99 ng/ml |
Creatine kinase isoenzyme, CKMB | 83 U/L |
Creatinine | 83.5 umol/L |
Urea nitrogen | 6.34 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 23.4 X10*9/L |
neutrophilic granulocyte percentage | 93.4 % |
Hb | g/L |
CRP | 80 mg/L |
Procalcitonin, PCT | 2.8 ng/ml |
Sequential Organ Failure Assessment | 分 |
Transfusion of Red Cells | |
Transfusion of Red Cells | U |
Plasma infusion | |
Plasma infusion | ml |
platelet transfusion | |
platelet transfusion | U |
APACHEⅡ | 分 |
Complication | no
|
prognosis | |
28-day mortality | |
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 天 |
duration in ICU | 天 |
duration of mechanical ventilation | 小时 |
ICU expenses | 元 |
Continuous Renal Replacement Therapy | |
Continuous Renal Replacement Therapy | 小时 |